The global urology surgical instruments market size was valued at USD 7.27 billion in 2016 and is projected to expand at a CAGR of 7.9% during the forecast period. Some of the key factors responsible for the growth of the market are rising geriatric population, increasing prevalence of urinary disorders, growing preference for minimally invasive surgeries, surging expenditure on R&D, and ongoing product launches by manufacturers.
The geriatric population is considered to be more susceptible to digestive disorders, incontinence, and chronic conditions, which require long-term care. Hence, rise in global geriatric population is expected to serve as a high impact rendering driver. Rise in geriatric population will also result in an increase in the number of surgeries performed. Advancing technologies, improving healthcare delivery services, and overall improvement in quality of life is contributing to increasing life expectancy of people around the world.
In recent years, there has also been an increase in incidence of chronic kidney disease (CKD) among the elderly population across the globe. According to National Health and Nutrition Examination Survey (NHANES) and National Kidney Foundation, about 12.1% of males suffer from CKD in U.S. The data also states that in 2013, more than 57.7% of new end-stage renal diseases or kidney failure cases occurred in men. About 57.3% patients receiving treatment for kidney failure in U.S. are male. NHANES data states that about 15.1% women suffer from CKDs. This alarming rise in patients suffering from urinary dysfunctions results in greater need for urology procedures, thereby fueling demand for surgical instruments.
Many manufacturers have been investing in R&D for development of new and technologically advanced products in the past few years. For instance, in FY 2017, the research and development expenses of Olympus Corporation stood at USD 355.21 million. Similarly, the R&D costs of Coloplast in 2016/17 were nearly USD 94.08 million (DKK 574 million). This has increased from USD 83.43 million (DKK 509 million) in 2015/16. These R&D investments aid in development and launch of new products in the market. For instance, in February 2017, Cook Medical launched Universa sets for percutaneous urinary drainage. These are available in different sizes to meet patients’ need and preference.
Based on type of product, the market is segmented into endoscopes, endovision systems, peripheral systems, and consumables and accessories. In 2016, the consumables and accessories segment held the largest share in the market; the segment is also anticipated to grow at the highest rate during the forecast period.
Repeated usage of these products and their disposable nature are major factors driving this segment. In addition, global rise in number of urology procedures is expected to boost the demand for these products in the coming years. Consumables and accessories are further segmented into stone baskets/retrieval devices and extractors, fluid flushing devices, stents, needle forceps and needle holders, drainage bags, clamps, biopsy devices, connecting tubes, distal attachments, overtubes, catheters, dilator sets and ureteral access sheaths, guidewires, surgical dissectors, and others. In 2016, guidewires held the largest share in the consumables and accessories segment and are expected to exhibit a strong CAGR during the forecast period.
In 2016, endoscopes held the second-largest share in the market by product. Increasing demand for minimally invasive techniques in diagnostics and therapeutics is a key factor driving the urology endoscopes market. Furthermore, rise in investments by private players, increase in grants or funds by public sector, and surge in number of hospitals and clinics are factors expected to boost demand for endoscopes over the forecast period.
Based on application, the urology surgical instruments market is segmented into chronic kidney diseases (CKD), benign prostatic hyperplasia (BPH), urinary stones, urinary incontinence (UI) and pelvic organ prolapse (POP), oncology, and others. In 2016, the chronic kidney diseases segment held the largest share in the market. This can be attributed to rising incidence of CKD, increasing number of clinical trials for new non-invasive procedures to treat these diseases, and initiatives by governments across the globe. According to the National Chronic Kidney Disease Fact Sheet, 2017 published by CDC, nearly 30 million adults, or 15% of the U.S. population, had CKD as of 2014. In addition, as many as 118,000 people in the country started treatment for ESRD in 2014 and 662,000 were living on chronic dialysis or with a kidney transplant in the same year.
The urinary incontinence and pelvic organ prolapse segment is anticipated to exhibit the highest growth rate during the forecast period. This is due to significant increase in the number of surgical procedures for urinary incontinence, growing awareness about incontinence, advancing technologies, and rising adoption of these products for managing incontinence. In addition, rise in number of surgical procedures for POP is expected to boost demand for urology surgical instruments in the coming years.
In 2016, North America dominated the global market with a share of 41.5%. Growing geriatric population in U.S. and Canada, rising incidences of urology cancers and disorders, increasing urology equipment purchases by hospitals, rise in number of urologists, positive reimbursement scenario, and increasing healthcare spending on urology disorders are some of the key factors likely to boost the regional market for urology surgical instruments during the forecast period.
U.S. is one of the key markets in the region and growth can be attributed presence of large patient population with urinary disorders, rising number of urology procedures, increasing hospital expenditure on purchase of urology surgical instruments, and incessant launch of technologically advanced products. In addition, availability of reimbursement for urology procedures is expected to boost the number of urology procedures conducted, and therefore demand for associated instruments, in the coming years.
The Asia Pacific market is anticipated to exhibit the highest CAGR of 8.4% over the forecast period. Rise in free trade agreements between Asian countries and western countries, increasing healthcare expenditure for urology by governments, stringent regulatory policies for usage of invasive devices, improving healthcare infrastructure in China and India, and rapid growth of medical tourism are expected to bolster market growth in the coming years. In addition, large number of private and public hospitals in China, Australia, New Zealand, Malaysia, Singapore, Japan, Indonesia, and India are purchasing new urology equipment to meet rising demand for urology procedures.
Some of the key market players are Olympus Corporation, Coloplast Group, Richard Wolf GmbH, KARL STORZ, Cook, Boston Scientific Corporation, Medtronic, Teleflex Incorporated, and Stryker. Technological innovations, new product launches, and partnerships are some of the key strategies adopted by these players to gain a competitive edge.
Base year for estimation
Actual estimates/Historical data
2014 - 2015
2017 - 2025
Revenue in USD Million & CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, MEA
U.S., Canada, Germany, U.K., Japan, China, Brazil, Mexico, South Africa
Revenue forecast, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global urology surgical instruments market report on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Monitors & Displays
Endoscopy Fluid Flushing Devices
Consumables & Accessories
Stone Baskets/Retrieval Devices and Extractors
Fluid Flushing Devices, Connecting Tubes, Clamps, Overtubes, and Distal Attachments
Dilator Sets and Ureteral Access Sheaths
Needle Forceps and Needle Holders
Application Outlook (Revenue, USD Million, 2014 - 2025)
Chronic Kidney Diseases (CKD)
Benign Prostatic Hyperplasia (BPH)
Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.